ITCI
Balyasny Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,257,912
| Closed | -$298M | – | 2613 |
|
|
2025
Q1 | $298M | Buy |
2,257,912
+2,118,252
| +1,517% | +$279M | 0.49% | 13 |
|
|
2024
Q4 | $11.7M | Buy |
+139,660
| New | +$11.7M | 0.02% | 637 |
|
|
2024
Q3 | – | Sell |
-406,714
| Closed | -$27.9M | – | 2447 |
|
|
2024
Q2 | $27.9M | Sell |
406,714
-3,920
| -1% | -$268K | 0.05% | 373 |
|
|
2024
Q1 | $28.4M | Buy |
410,634
+100,641
| +32% | +$6.96M | 0.05% | 375 |
|
|
2023
Q4 | $22.2M | Buy |
+309,993
| New | +$22.2M | 0.04% | 416 |
|
|
2023
Q3 | – | Sell |
-130,607
| Closed | -$8.27M | – | 2291 |
|
|
2023
Q2 | $8.27M | Buy |
130,607
+123,282
| +1,683% | +$7.81M | 0.02% | 653 |
|
|
2023
Q1 | $397K | Buy |
7,325
+6,657
| +997% | +$360K | ﹤0.01% | 1593 |
|
|
2022
Q4 | $35.4K | Sell |
668
-4,640
| -87% | -$246K | ﹤0.01% | 1962 |
|
|
2022
Q3 | $247K | Buy |
+5,308
| New | +$247K | ﹤0.01% | 1780 |
|
|
2022
Q2 | – | Sell |
-31,967
| Closed | -$1.96M | – | 2778 |
|
|
2022
Q1 | $1.96M | Buy |
+31,967
| New | +$1.96M | 0.01% | 1085 |
|
|
2018
Q4 | – | Sell |
-508,750
| Closed | -$11M | – | 1628 |
|
|
2018
Q3 | $11M | Buy |
508,750
+50,859
| +11% | +$1.1M | 0.05% | 384 |
|
|
2018
Q2 | $8.09M | Buy |
457,891
+55,765
| +14% | +$985K | 0.04% | 458 |
|
|
2018
Q1 | $8.47M | Buy |
402,126
+291,973
| +265% | +$6.15M | 0.04% | 488 |
|
|
2017
Q4 | $1.6M | Sell |
110,153
-29,200
| -21% | -$423K | 0.01% | 978 |
|
|
2017
Q3 | $2.2M | Buy |
+139,353
| New | +$2.2M | 0.01% | 760 |
|
|
2016
Q2 | – | Sell |
-55,100
| Closed | -$1.53M | – | 1277 |
|
|
2016
Q1 | $1.53M | Buy |
55,100
+45,730
| +488% | +$1.27M | 0.01% | 544 |
|
|
2015
Q4 | $504K | Buy |
+9,370
| New | +$504K | ﹤0.01% | 693 |
|
|
2015
Q3 | – | Sell |
-50,000
| Closed | -$1.6M | – | 1219 |
|
|
2015
Q2 | $1.6M | Buy |
+50,000
| New | +$1.6M | 0.01% | 543 |
|